Huntington disease

267,866views

Huntington disease

12345

12345

Introduction to the skeletal system
Introduction to the cardiovascular system
Introduction to the muscular system
Anatomical terminology
Anatomy of the muscles and nerves of the posterior abdominal wall
Anatomy of the abdominal viscera: Innervation of the abdominal viscera
Enteric nervous system
Physiological changes during exercise
Pentose phosphate pathway
Glycolysis
Electron transport chain and oxidative phosphorylation
Development of the face and palate
Pharyngeal arches, pouches, and clefts
Development of the teeth
Development of the tongue
Citric acid cycle
Gluconeogenesis
Nitrogen and urea cycle
Amino acid metabolism
Fatty acid synthesis
Ketone body metabolism
Fatty acid oxidation
Cholesterol metabolism
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Gaucher disease (NORD)
Cystinosis
Ornithine transcarbamylase deficiency
Familial hypercholesterolemia
Disorders of carbohydrate metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Disorders of fatty acid metabolism: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of amino acid metabolism: Pathology review
Carbohydrates and sugars
Proteins
Fats and lipids
Vitamin B12 deficiency
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Nernst equation
Nernst equation
Peroxisomal disorders: Pathology review
Peroxisomal disorders: Pathology review
Nuclear structure
Nuclear structure
Amino acids and protein folding
Amino acids and protein folding
Nucleotide metabolism
Nucleotide metabolism
Mitosis and meiosis
Mitosis and meiosis
Adenosine deaminase deficiency
Adenosine deaminase deficiency
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
DNA cloning
Fluorescence in situ hybridization
Gel electrophoresis and genetic testing
Lactose intolerance
Down syndrome (Trisomy 21)
Edwards syndrome (Trisomy 18)
Patau syndrome (Trisomy 13)
Huntington disease
Fragile X syndrome
Myotonic dystrophy
Friedreich ataxia
Prader-Willi syndrome
Angelman syndrome
Polycystic kidney disease
Familial adenomatous polyposis
Alpha-thalassemia
Beta-thalassemia
Miscellaneous genetic disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Autosomal trisomies: Pathology review
Mitochondrial myopathy
Gestational diabetes
Placental abruption
Preeclampsia & eclampsia
Fetal alcohol syndrome
Testicular tumors: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Uterine disorders: Pathology review
Cervical cancer: Pathology review
Ovarian cysts and tumors: Pathology review
Vaginal and vulvar disorders: Pathology review
Breast cancer: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Complications during pregnancy: Pathology review
Amenorrhea: Pathology review
Adrenergic antagonists: Alpha blockers
Androgens and antiandrogens
PDE5 inhibitors
Aromatase inhibitors
Uterine stimulants and relaxants
Estrogens and antiestrogens
Progestins and antiprogestins

Transcript

Watch video only

Huntington disease, or HD, is a rare neurodegenerative disease that involves a repeated sequence of DNA that causes an abnormal protein to form, leading to abnormal movements and cognitive problems.

Huntington disease is an autosomal dominant genetic disorder, which means that one affected copy of a gene is enough to cause disease. Affected people are typically present in each generation, because an affected person (male or female) has a 50% chance of passing on the affected gene to a child, which causes that child to have the disease.

In most people, a gene called huntingtin or HTT on chromosome 4, contains a triplet repeat, where the nucleotides C, A, and G are repeated 10-35 times in a row. In people with Huntington disease, this repeat goes on for 36 or more times in a row. CAG codes for the amino acid glutamine, so people with Huntington disease patients will have 36 or more glutamines in a row in the huntingtin protein. So, in addition to being a triplet repeat disorder, HD is, more specifically, a “polyglutamine” disease.

The specific way in which extra glutamines cause HD symptoms isn’t fully worked out, but some clues are that the mutated protein aggregates within the neuronal cells of the caudate and putamen of the basal ganglia causing neuronal cell death. Cell death might be related to excitotoxicity – which is excessive signaling of these neurons, which leads to high intracellular calcium.

The expanded CAG repeats not only affect the huntingtin protein – they affect DNA replication itself. When copying the HTT gene, DNA polymerase can basically lose track of which CAG it’s on and accidently add extra CAGs. Since as a zygote develops into a fetus and eventually into a full adult, by the time sperm and eggs are created, several dozen cell divisions, each with a round of DNA replication have taken place, and so there have already been ample opportunities for repeat expansion, and the more repeats that’re added, the more unstable it gets.

This expansion of the originally inherited gene means a child of a parent with HD can inherit even more CAG repeats than the parent did. The higher the number of repeats in the protein, the earlier the age when a person starts having symptoms. This phenomenon is called anticipation, which means that Huntington disease families often show earlier symptom onset with each generation. Even repeats of 27-35 CAGs can expand occasionally; these are called “pre-mutation” alleles, since they don’t cause the disease, but they’re set-up for developing a mutation of 36 or more CAGs.

This process of adding more repeats is called repeat expansion and it happens way more in the production of sperm than of eggs, so both anticipation and new disease alleles generally happens when the father is the affected parent. When a person has 40+ repeats, they show 100% penetrance and they will have the disease. For reasons that remain unknown, people with 36-39 repeats can show reduced penetrance; some may have symptoms while others may not. Because of this penetrance, the test for HD, which counts the number of CAG repeats, is really good at determining whether HD will develop in an at-risk individual.